Abstract
Hypertrophic cardiomyopathy remains underdiagnosed despite a growing number of effective treatment interventions that can improve care. Multimodality imaging has become integral to diagnosing and managing hypertrophic cardiomyopathy, providing a comprehensive assessment of the disease. In particular, it enhances the diagnostic accuracy and deepens the understanding of the mechanisms underlying patient symptoms, enabling targeted therapeutic approaches. Additionally, multimodality imaging allows for better risk stratification, assessment of therapy response, and guidance of interventions to deliver personalized medicine. The practical tools outlined in this review can help providers integrate multimodality imaging strategies to provide better care and improve the patient experience.
| Original language | English (US) |
|---|---|
| Article number | 2606 |
| Journal | Journal of Clinical Medicine |
| Volume | 14 |
| Issue number | 8 |
| DOIs | |
| State | Published - Apr 2025 |
| Externally published | Yes |
Keywords
- hypertrophic cardiomyopathy
- imaging targets
- multimodality imaging
ASJC Scopus subject areas
- General Medicine